UTA In The News — Monday, March 1, 2021
Emerging cancer treatments
Jon Weidanz, UT Arlington’s associate vice president for research, wrote a commentary for the journal Science about emerging protein-based immunotherapies that could lead to highly effective “off-the-shelf” cancer treatments for more patients, Science reported. Researchers have shown in mice that designer antibodies can curb the growth of tumors by targeting two of cancer’s most infamous offenders—the proteins RAS and p53.
Grant studies how blasts affect brain
Ashfaq Adnan, a UT Arlington researcher and professor of mechanical and aerospace engineering, has received an Office of Naval Research grant to examine the mechanics of how blast-like events cause damage to the brain, Targeted News Service, Medical Xpress, Mirage News, 7thSpace.com, BollyInside and Agenparl, an Italian news agency, reported.\
Vaccines going to affluent neighborhoods
Most of the Tarrant County residents who have received a COVID-19 vaccine are from predominantly white affluent neighborhoods, highlighting officials’ struggles to reach minority and low-income neighborhoods, the Fort Worth Star-Telegram reported. Jason Shelton, director of the Center for African American Studies at UT Arlington, said that might be due to the limited supply of vaccines. He said he believes that the picture will become more clear once the vaccines are more widely available.
UT Arlington joining education effort
The University of Texas at Arlington is joining the Tarrant To & Through Partnership, a community-wide collaborative effort focused on ensuring that more Tarrant County students obtain postsecondary credentials and have the training and skills to thrive in today’s workforce, Patch and ArlingtonTX.gov reported.
Sundt Foundation awards
The Sundt Foundation has awarded $11,400 in grants to five non-profits in North Texas, including UT Arlington’s Kinesiology Sports, Leadership & Management program, the Fort Worth Business Press reported.